Whole brain radiation with supplementary boost for patients for unique brain metastasis from a primitive lung cancer;Expérience de l'irradiation encéphalique totale avec escalade de dose focalisée pour le traitement des métastases cérébrales uniques d'un carcinome bronchopulmonaire

Cancer/Radiotherapie

Volumn 15, Issue 5, 2011, Pages 426-429

  Levy A ^a   Chargari, C ^a,b   Lamproglou, I ^a   Mazeron, J J ^a,c   Krzisch, C ^d   Assouline, A ^a,c,d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b University of Paris Descartes   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Brain metastases; Prognostic factors; Radiation boost; Whole brain radiotherapy

Indexed keywords

ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT; FOLLOW UP; HUMAN; LINEAR ACCELERATOR; LUNG CANCER; MAGNETIC AND ELECTROMAGNETIC EQUIPMENT; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CRANIAL IRRADIATION; DOSE FRACTIONATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79961209606     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2011.03.007     Document Type: Article

References (21)

1. Belot A., Grosclaude P., Bossard N., Jougla E., Benhamou E., Delafosse P., et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008, 56:159-175.
2. Borgelt B., Gelber R., Larson M., Hendrickson F., Griffin T., Roth R. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981, 7:1633-1638.
3. Broadbent A.M., Hruby G., Tin M.M., Jackson M., Firth I. Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients. Radiother Oncol 2004, 71:259-265.
4. Chargari C., Campana F., Pierga J.Y., Védrine L., Ricard D., Le Moulec S., et al. Whole-brain radiation therapy in breast cancer patients with brain metastases. Nat Rev Clin Oncol 2010, 7:632-640.
5. Chargari C., Kirova Y.M., Diéras V., Castro Pena P., Campana F., Cottu P.H., et al. Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients. J Neurooncol 2009, 93:379-384.
6. Chargari C, Riahi Idrissi H, Pierga JY, Bollet MA, Diéras V, Campana F, et al. Preliminary results of whole brain radiotherapy with concurrent trastuzumab as a potential radiosensitizer for treatment of brain metastases in breast cancer patients. Int J Radiat Oncol Biol Phys 2010, [Epub ahead of print].
7. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751.
8. Gavrilovic I.T., Posner J.B. Brain metastases: epidemiology and pathophysiology. J Neuroncol 2005, 75:5.
9. Hoskin P.J., Crow J., Ford H.T. The influence of extent and local management on the outcome of radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 1990, 19:111-115.
10. Johnson J.D., Young B. Demographics of brain metastasis. Neurosurg Clin N Am 1996, 7:337.
11. Lagerwaard F.J., Levendag P.C., Nowak P.J., Eijkenboom W.M., Hanssens P.E., Schmitz P.I. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999, 43:795-803.
12. Noël G. La radiothérapie des métastases cérébrales. Cancer Radiother 2006, 10:437-443.
13. Noël G., Mazeron J.J. Réirradiation cérébrale des tumeurs primitives malignes ou secondaires. Cancer Radiother 2010, 14:421-437.
14. Patchell R. Brain metastases. Handbook Neurol 1997, 25:135.
15. Patchell R. The management of brain metastases. Cancer Treat Rev 2003, 29:533-540.
16. Posner J.B. Brain metastases: 1995. A brief review. J Neuro-oncol 1996, 27:287-293.
17. Rades D., Haatanen T., Schild S.E., Dunst J. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases. Cancer 2007, 110:1345-1350.
18. Rades D., Pluemer A., Veninga T., Dunst J., Schild S.E. A boost in addition to whole brain radiotherapy improves patient outcome after resection of one or two brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer 2007, 110:1551-1559.
19. Schlienger M., Nataf F., Huguet F., Pene F., Foulquier J.N., Orthuon A., et al. Place de l'irradiation stéréotaxique hypofractionnée dans le traitement des métastases cérébrales. Cancer Radiother 2010, 14:119-127.
20. Simon J.M., Noël G., Boisserie G., Cornu P., Mazeron J.J. Radiothérapie intracérébrale en conditions stéréotaxiques. Cancer Radiother 2002, 6:144-154.
21. Tsao M.N., Lloyd N.S., Wong R.K., Rakovitch E., Chow E., Laperriere N. Radiotherapeutic management of brain metastases: a systematic review and metaanalysis. Cancer Treat Rev 2005, 31:256-273. Supportive Care Guidelines Group of Cancer Care Ontario's Program in evidence-based care.